Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/37123

Target Organs and Levels of Evidence for TR-577

Toxicology and Carcinogenesis Studies of a Nondecolorized Whole Leaf Extract of Aloe Barbadensis Miller (Aloe Vera) (CASRN ALOEVLEAFEXT) in F344/N Rats and B6C3F1 Mice (Drinking Water Study)

Chemical (Study Title)
CASRN
Peer Review DatePrimary UsesRoute/Exposure LevelsStudy Laboratory
Aloe vera whole leaf extract (native)
ALOEVLEAFEXT
04/05/2011Recognized as a therapeutic dermatologic agent; extracts incorporated in a variety of topical health care products and cosmeticsDosed-Water
R: 0, 0.5%, 1.0% or 1.5%; M: 0, 1%, 2% or 3%
National Center for Toxicological Research

Levels of Evidence

Male Rats: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Large Intestine: Proximal colon adenoma 0/44 0/44 7/46 10/41; proximal colon carcinoma 0/44 0/44 4/46 4/41; cecum adenoma 0/46 0/45 8/48 8/48; cecum carcinoma 0/46 0/45 1/48 2/48; ascending colon adenoma 0/47 0/47 19/48 8/46; ascending colon carcinoma 0/47 0/47 4/48 8/46; transverse colon adenoma 0/47 0/47 6/47 3/47; transverse colon carcinoma 0/47 0/47 1/47 1/47; adenoma 0/47, 0/48 26/48 23/48; carcinoma 0/47 0/48 10/48 14/48; all sections, adenoma and carcinoma combined 0/47 0/48 28/48 31/48
Non-Neoplastic Lesions
  • Mesenteric lymph node: hyperplasia; cystic degeneration
  • Glandular stomach: mucosa hyperplasia
  • Small intestine: jejunum mucosa hyperplasia
  • Large intestine: proximal colon mucosa hyperplasia; cecum mucosa hyperplasia; ascending colon mucosa hyperplasia; transverse colon mucosa hyperplasia; descending colon mucosa hyperplasia; colon mucosa hyperplasia; rectum mucosa hyperplasia; cecum dilatation
Female Rats: Clear Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Large Intestine: Proximal colon adenoma 0/43 0/45 4/42 5/39; proximal colon carcinoma 0/43 0/45 2/42 4/39; cecum adenoma 0/47 0/48 1/47 6/48; ascending colon adenoma 0/47 0/48 1/46 5/46; all sections, adenoma 0/48, 0/48 6/48 13/48; carcinoma 0/48 0/48 3/48 4/48; adenoma and carcinoma combined 0/48 0/48 8/48 15/48
Non-Neoplastic Lesions
  • Mesenteric lymph node: hyperplasia, cystic degeneration
  • Glandular stomach: mucosa hyperplasia; forestomach inflammation; forestomach hyperplasia
  • Small intestine: ileum mucosa hyperplasia
  • Large intestine: proximal colon mucosa hyperplasia; cecum mucosa hyperplasia; ascending colon mucosa hyperplasia; transverse colon mucosa hyperplasia; descending colon mucosa hyperplasia; rectum mucosa hyperplasia; cecum dilatation; proximal colon inflammation
Male Mice: No Evidence
TypeOrgan/Tissue (Lesion)
Non-Neoplastic Lesions
  • Mesenteric lymph node: cellular infiltration
  • Large intestine: ascending colon, goblet cell hyperplasia; transverse colon, goblet cell hyperplasia; descending colon, goblet cell hyperplasia
  • Nasal Cavity: hyaline droplet
Female Mice: No Evidence
TypeOrgan/Tissue (Lesion)
Non-Neoplastic Lesions
  • Glandular stomach: epithelial hyperplasia
  • Large intestine: ascending colon, goblet cell hyperplasia; transverse colon, goblet cell hyperplasia; descending colon, goblet cell hyperplasia